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Serial lesionsCoronary intervention is increasingly performed in complex disease with tandem and diffuse disease. Pressure
wires enable detailed assessment of the physiological signiﬁcance of a stenosis but in the presence of tandem
disease, predicting the impact of a stenting a given stenosis can be difﬁcult and is impeded by ﬂow interaction
between stenoses under hyperemia. In this review, we consider the physiological difﬁculties posed by ﬂow
interaction under hyperemia and consider alternative approaches such as assessment under baseline conditions.
Speciﬁcally we consider the potential value of the iFR-Pullback approach and its capacity to enable Virtual-PCI,
which may assist in planning intervention.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Pressure wire technology has revolutionised our treatment of coro-
nary disease, by identifying clinically important stenoses. Physiology
provides an objective marker to support intervention by identifying
haemodynamically signiﬁcant lesions [1,2]. However, currently used
physiological indices have limited ability to isolate individual lesion sig-
niﬁcance in vessels withmultiple lesions. The prevalence of such diffuse
coronary disease is increasing and accurate assessment to guide appro-
priate therapy is paramount.
Current physiological assessment in such vessels does not automat-
ically indicate the haemodynamic improvement thatwould be expected
post stenting. The clinical utility of an index would be enhanced if it
could inform the clinician of the likely effect of any intervention. A
tool that can inform the clinician of the haemodynamic beneﬁt of
inserting a stent at a particular point in the vessel, over a speciﬁc length
would help clinicians rationalise their revascularisation procedure.
However, predicting the haemodynamic response to stenting has been
difﬁcult and up to now complex and time consuming. Overcoming
these barriers, and amalgamating pressure wire and imaging technolo-
gy to aid in decision making is the next frontier for an interventional
cardiology community that is being confronted by an increasing preva-
lence of diffuse coronary artery disease. This review article will discuss
some of the physiological aspects of tandem lesion assessment, theulatory Health, National Heart
2 1LA. Tel.: +44 7971 831328;
vies).
. This is an open access article underlimitations of current invasive modalities and the potential for new in-
dices that utilise the vast improvement in pressure wire technology.1. Assessment of individual stenoses in tandem lesions or diffusely
diseased vessels – an unmet clinical need
In unobstructed vessels, ﬂow during hyperemia can be many fold
higher than that observed during rest. In the presence of a single steno-
sis, resting ﬂow is typically maintained while hyperemic ﬂow dimin-
ishes for any stenosis N40–50% in anatomical severity (Fig. 1, upper
panel) [3]. Itwas thisﬁnding in animals that lead to the concept that ste-
noses N50% are haemodynamically important. Since for practical rea-
sons we are typically reliant upon pressure measurements rather than
ﬂow measurements, then understanding pressure-ﬂow relationships
is essential.
The degree of pressure drop across a stenosis is dependent upon the
(1) stenosis severity and (2) the amount ﬂow across it. Using ﬂow
velocity as a surrogate for volumetric ﬂow, this relationship between
stenosis pressure gradient and ﬂow can be measured to yield a speciﬁc
ﬁngerprint of the stenosis; with each single stenosis having a speciﬁc
haemodynamic signature as originally described by Gould [3,4].
In the situation of a vessel with two tandem lesions, hyperemic ﬂow
across the proximal lesion is a function not only of the stenosis geome-
try but also the effect of the second, distal lesion. Similarly hyperemic
ﬂow across the second lesion is a function of its speciﬁc geometry and
its inlet ﬂow, which is inﬂuenced by the proximal stenosis (Fig. 2). As
a result, a pressure assessment in the distal vessel under ‘maximal
hyperaemia’ will not be speciﬁc to either stenosis, rather it informs usthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The expected behaviour of hyperemic and resting ﬂow after removal of stenosis. Upper panel. Pioneering studies demonstrated that resting ﬂow is preserved until stenoses are
critical or subtotally occluded. Hyperemic ﬂow falls in the presence of any stenosis but does so signiﬁcantly as stenoses exceed 40-50%. Lower panel. In Tandem stenoses (A), a measure-
ment ofﬂowat the blackmarker (•)will elicit a ﬂowvalue as denoted by the blackdot on theupper panel. In (B), the distal stenosis has been stented. Under hyperemic conditions,ﬂowwill
have increased signiﬁcantly (red dot); however, under resting conditions, there is minimal change expected.
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surgical revascularisation is being considered, where a graft is posi-
tioned distally, then this may be helpful information. However, it is
not possible to determine an accurate FFR for each individual stenosis.
Due to the sensitivity of hyperaemic ﬂow to the presence of proximal
or distal disease, a measurement of FFR between two tandem stenoses
will differ from that measured after one of the stenoses is treated.
Therefore, placing the pressure wire between tandem stenoses toFig. 2. Tandem stenoses cause ﬂow interaction under hyperemic conditions. The presence of tw
measurements. Formulae are available to estimate the FFR of a given stenosis without the impattempt to understand the ﬂow limitation caused by the proximal
stenosis can be misleading [5]. This is because the presence of the distal
stenosis means the increase in ﬂow caused by the hyperaemic agent is
not transmitted uniformly though the vessel; as a result the measured
pressure distal to the proximal stenosis may be higher than may
actually be the case, causing the severity of the proximal stenosis to be
underestimated. The removal of the distal stenosis by intervention
will increase hyperaemic ﬂow and thereby change the pressure ratioo ormore stenoses creates complex interaction of ﬂow and thereby impacts upon pressure
act of another but requires balloon occlusion of the stenosis in question (Pw).
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interaction between stenoses and determine an accurate FFR for the
residual stenosis, the second lesion must be treated and physiological
assessment must then be repeated.
Complex formulae have been derived in an attempt to try and
overcome these difﬁculties but are difﬁcult to apply in the catheter
laboratory (Fig. 2) [6,7]. They require a commitment to ballooning
one of the stenoses for determination of wedge pressure and when
there is uncertainty over stenoses, an interventionalist would prefer
to avoid vessel trauma. A more practical solution to circumvent this
limitation is the process of performing multiple hyperaemic mea-
surements whist pulling the pressure wire back along the length of
the artery. This aims to demonstrate where in the vessel the greatest
steps in pressure gradient are present. It does not overcome the issue
of stenosis interaction but can be used to help a cardiologist decide
which lesion is likely to be causing most of the pressure loss. Such
an approach only offers a crude estimate of the severity of each ste-
nosis and the issue remains that, after stenting, the pattern of ﬂow
in the vessel will change, rendering the initial assessment of any
residual stenosis inaccurate. Therefore such gradients cannot not
predict coronary haemodynamics post-PCI [5].
These difﬁculties imposed by hyperemia has hindered the develop-
ment of predictive systems that can model the physiological result
of stenting in the presence of multiple lesions [6,7]. As a result this is
currently not possible in clinical practice. A modality that can facilitate
stenosis speciﬁc assessmentwould add signiﬁcant value in themanage-
ment of these patients. Potentially itmay permit tailoring of the stenting
strategy to optimise physiological outcome.
2. Baseline physiology provides a potential solution to tandem
lesion assessment
A potential solution for the assessment of tandem lesions is to use
the unique characteristics of baseline physiology. Auto-regulatory
mechanisms ensure resting ﬂow is stable and changes little regardless
of stenosis severity [3,8]. The distalmicrocirculatory bed, a key governor
of coronary ﬂow, dilates under resting conditions to maintain resting
ﬂow even when severe epicardial artery narrowings are present [9].
Whilst ﬂow is maintained, this is at the expense of resting distal coro-
nary pressure. The dilation of themicrocirculation causes distal pressure
to fall, generating a pressure gradient that is essential to maintain coro-
nary ﬂow. It is this pressure gradient that is detected bymodern high ﬁ-
delity pressure wires, permitting stenosis assessment under basal
conditions [9–11].
Whilst baseline ﬂow ismaintained constant [8] until almost subtotal
occlusion of the vessel, hyperaemic ﬂow changes dramatically accord-
ing to the presence or absence of distal and proximal disease (Fig. 2).
This means that the basal state is uniquely suited to the assessment of
vessels with diffuse or tandem lesions; because basal ﬂow across the le-
sion of interest is expected to be negligibly affected by other lesions in
the vessel (Fig. 1) provided they are not critical or subtotal occlusions.
Even if there is some interaction under resting conditions at a given
point, the interaction is expected to be very small and much less than
that seen under hyperemia.
This minimal interaction between the stenoses means that a given
trans-stenotic pressure ratio measured at a particular point in a vessel
is less likely to be affected by other stenoseswithin the vessel. Similarly,
the haemodynamic assessment of the stenosis would not be affected
when another stenosis in the vessel is treated by stenting, since the
nature of resting ﬂow suggests that there would be minimal change in
resting ﬂow after stenting typical stenoses. This allows several assess-
ments of the coronary artery that are clinically useful, such as:
1. Evaluation of the stenosis burden of the complete vessel; providing a
cumulative assessment of all stenoses in that territory. This is also
currently possible with hyperaemic measures.2. Quantiﬁcation of the impact of individual stenoses within a diffusely
diseased vessel or a vessel with tandem stenoses; permitting the dif-
ferentiation of stenoses according to their magnitude of contribution
to the overall disease burden of the vessel – impossible with current
hyperaemic measures.
3. Prediction of the physiological effect of treating a particular stenosis
within the vessel; permitting intervention according to the likely
physiological gain. This is not possible with current hyperaemic
measures but is particularly advantageous for diffusely diseased vessels
as it may prevent the clinician from embarking on a revascularisation
strategy thatmay improve the appearance of the vessel but not improve
the blood ﬂow to the subtended territory.
Resting ﬂow therefore offers unique properties that may overcome
the difﬁculties seen during hyperaemia. A pressure wire pullback
under basal conditions may therefore offer an innovation to improve
physiological assessment in vessels with diffuse or tandem coronary
disease by providing stenosis speciﬁc information. For such an innova-
tion to be readily applicable to day-to-day practice, the approach must
be simple, glean the most information from the basal haemodynamics,
easy to perform and be done using routinely available pressure wires.
3. Instantaneous wave-free ratio (iFR) utilises basal physiology to
isolate the haemodynamic impact of individual stenoses in diffusely
diseased vessels
iFR is a resting index of stenosis severity that is measured without a
vasodilator. It is the ratio of distal and proximal pressures over the
wave-free period, a speciﬁc part of diastole during which coronary
ﬂow velocity is naturally at its highest [10]. This higher ﬂow velocity
allows iFR to assess higher pressure gradients across stenoses than pos-
sible by using the complete cardiac cycle whilst also preserving the key
characteristic of constant ﬂow [9]. As a result iFR has a greater ability to
identify small gradients pertinent to the assessment of a diffusely
diseased vessel [9,12].
We have evaluated the instantaneous wave-free ratio (iFR) for the
assessment of diffuse disease to ascertain the potential clinical utility
of iFR in this domain. If measured continuously during a pressure wire
pullback a haemodynamic map of the coronary artery can be created
[13]. Importantly, the higher ﬂow velocity during the iFR window
when compared to resting whole cycle window provides greater
pressure-spatial resolution.
With the advent of modern computer processing, it is possible to
integrate the pressure wire data to plot the change in iFR over a given
length of vessel, and thereby calculate the change in iFR per millimetre
of vessel, a marker of pressure-loss intensity (iFR intensity =ΔiFR/
distance, Fig. 3) [13].
The value of mapping the iFR intensity in diffusely diseased vessels
enables identiﬁcation of any focal areas of disease that may cause the
predominant pressure loss (Fig. 3), and therefore be targeted for percu-
taneous intervention. The percentage contribution of pressure loss can
be displayed to assist decision-making. The mapping can be displayed
in a number of differentways (Fig. 3).With co-registration, the pressure
wire pullback can become integrated with the angiographic ﬁndings to
enhance the ease of understanding of the data. ‘Dots’ representing units
of pressure loss can help identify which stenoses are most haemody-
namically important. In addition, iFR intensity plotted as a function of
distance can give additional information regarding the length over
which the pressure drop occurs (Fig. 3). This may assist in identifying
which lesions in the vessel contribute most to pressure loss and allow
operators to estimate the physiological length of a stenosis to help de-
cide between different revascularisation strategies (PCI/CABG) (Fig. 4).
This approach also allows the operator to predict the haemodynamic
effect of their intervention by modelling the expected improvement in
coronary physiology for a given stenting approach [13]. Since length
has been integrated into the information, a haemodynamic map can
Fig. 3. iFR Pullback can display iFR-intensity and integrate onto angiography. A. Right coronary artery with 4 discrete stenoses. A pressure wire is pulled back at rest from the distal vessel
the proximal vessel at 0.5 mm/sec using amotorised device. The red-dots correspond to the iFR-intensity plot shown in B lower panel. The numbers correspond to the four discrete phys-
iological lesions identiﬁed on iFR-pullback. B. Upper panel: The red line shows the iFR-Pullback. Focal lesions are visualised as sudden stepswhile diffuse disease is a gradual slope. Distance
is used as the x-axis since the distance of the wire-movement is known enabling estimation of the physiological length of the lesion. Lower panel: The iFR-intensity (ΔiFR/mm) can be
plotted as bar chart to identify where the greatest pressure loss in the vessel.
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predict physiological improvement from stenting prior to PCI (Fig. 4).
In simple disease, this could be used to predict the post-intervention
iFR result. In more complex disease, such technology permits the clini-
cian to simulate multiple different stenting approaches to identify the
most appropriate for the most favourable haemodynamic outcome
(Fig. 3). In the iFR-Pullback study, complex tandem stenoses and diffuse
diseasewas assessed in patients undergoing coronary intervention [13].
Using iFR-Pullback it was possible to predict an expected iFR value for
the treatment of a selected stenosis. When compared to the real-
world observed iFR value achieved after stenting, there was a close
relationship between the predicted delta and a close relationship on
Bland-Altman analysis [13]. There was no signiﬁcant bias in theFig. 4. Virtual PCI can be performed on iFR-Pullback to calculate the effect of removing a stenos
displayed as small red dots representing pressure loss and is integrated onto the angiogram. B. D
selected for removal, and computer algorithmswillmodel the impact upon the rest of the vesse
treatment; both stenoses are required for an optimal result.prediction and overall, it was possible to predict the post-PCI iFR result
within 5% error even in complex disease [13].
iFR-Pullback measurements can be made using manual pullback of
pressure wires. Performed over 20 to 30 seconds, physiological data
can be processed ‘live’ and display the resting iFR gradients throughout
the vessel.
The concepts of producing a physiological map of the vessel, to aid
planning and virtual PCI represent a change in the application of physi-
ological measurements. Previously, there may have been temptation to
use physiology as a binary value, with a ‘stent everything’ and ‘stent
nothing’ approach. However, pullback assessment of complex and dif-
fuse disease exposes physiological assessment as a continuous variable
along the length of the vessel. This objective physiological approachis. A. A resting iFR-Pullback is performed on a RCAwith signiﬁcant disease. iFR-intensity is
ifferent stenting strategies can be considered. C. On the iFR-pullback trace, a stenosis can be
l. Removing stenosis 1 or 2 alonewill not give the vessel an iFRwell above the threshold for
171S.S. Nijjer et al. / Cardiovascular Revascularization Medicine 16 (2015) 167–171has the potential to offer an important adjunct to the armamentariumof
the interventional cardiologist.
One area of potential change may be that focal areas causing pressure
losswithin a vessel couldbe speciﬁcally targeted for intervention. Presently,
coronary intervention is typically performed from normal-to-normal seg-
ments with a view to avoid geographical miss, which has been associated
with higher rates of target vessel revascularisation, myocardial infarction;
imaging studies with IVUS have suggested stent edge plaque burden
and geographical miss are associated with early stent thrombosis and
restenosis [14,15]. However, it is also known that excessive stent length is
associated with increased lumen loss, which may itself have further impli-
cations [16]. Achieving an optimal physiological result without total cover-
age of all possible atheroma may be a compromise. With the advent of
physiological mapping there is now an opportunity to assess this in detail.
In an hypothesis generating analysis from the iFR-Pullback study, it was
noted that physiological lesion length was signiﬁcantly shorter than ana-
tomical length and the total stent length deployed [13]. Furthermore,
virtual-PCI analysis suggested optimal physiological results could be
achieved with signiﬁcantly less stent length. At present these concepts are
nascent, and there is no outcomedata for either approach of physiologically
focused stenting versus stenting covering larger lengths. Detailed future
studies will be required before such an approach can be advocated.
4. Conclusion
Physiological assessment has already demonstrated great value in
the management of coronary disease. iFR pullback is an innovation
that reﬁnes this technology to aid clinical decisionmaking in diffuse cor-
onary artery disease and vessels with tandem lesions.
References
[1] Meuwissen M, Siebes M, Chamuleau SAJ, Tijssen JGP, Spaan JAE, Piek JJ.
Intracoronary pressure and ﬂow velocity for hemodynamic evaluation of coronary
stenoses. Expert Rev Cardiovasc Ther 2003;1:471–9.
[2] Van de Hoef TP, Meuwissen M, Escaned J, Davies JE, Siebes M, Spaan JAE, et al. Frac-
tional ﬂow reserve as a surrogate for inducible myocardial ischaemia. Nat Rev
Cardiol 2013;10:439–52.[3] Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical
coronary stenosis: instantaneous ﬂow response and regional distribution during
coronary hyperemia as measures of coronary ﬂow reserve. Am J Cardiol 1974;33:
87–94.
[4] Gould KL. Pressure-ﬂow characteristics of coronary stenoses in unsedated dogs at
rest and during coronary vasodilation. Circ Res 1978;43:242–53.
[5] Kim H-L, Koo B-K, Nam C-W, Doh J-H, Kim J-H, Yang H-M, et al. Clinical and Physi-
ological Outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Inter-
vention in Patients With Serial Stenoses Within One Coronary Artery. JACC
Cardiovasc Interv 2012;5:1013–8.
[6] Bruyne BD, Pijls NHJ, Heyndrickx GR, Hodeige D, Kirkeeide R, Gould KL. Pressure-
derived fractional ﬂow reserve to assess serial epicardial stenoses: theoretical
basis and animal validation. Circulation 2000;101:1840–7.
[7] Pijls NHJ, Bruyne BD, Bech GJW, Liistro F, Heyndrickx GR, Bonnier HJRM, et al.
Coronary pressure measurement to assess the hemodynamic signiﬁcance of serial
stenoses within one coronary artery validation in humans. Circulation 2000;102:
2371–7.
[8] Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between
myocardial blood ﬂow and the severity of coronary-artery stenosis. N Engl J Med
1994;330:1782–8.
[9] Sen S, Asrress KN, Nijjer S, Petraco R,Malik IS, Foale RA, et al. Diagnostic classiﬁcation
of the instantaneous wave-free ratio is equivalent to fractional ﬂow reserve and is
not improved with adenosine administration: results of CLARIFY (Classiﬁcation Ac-
curacy of Pressure-Only Ratios Against Indices Using Flow Study). J Am Coll Cardiol
2013;61:1409–20.
[10] Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, et al. Development and val-
idation of a new adenosine-independent index of stenosis severity from coronary
wave–intensity analysis. J Am Coll Cardiol 2012;59:1392–402.
[11] Petraco R, Escaned J, Sen S, Nijjer S, Asrress KN, Echavarria-Pinto M, et al. Classiﬁca-
tion performance of instantaneous wave-free ratio (iFR) and fractional ﬂow reserve
in a clinical population of intermediate coronary stenoses: results of the ADVISE reg-
istry. EuroIntervention 2013;9:91–101.
[12] Nijjer SS, Sen S, Petraco R, Sachdeva R, Cuculi F, Escaned J, et al. Improvement in cor-
onary haemodynamics after percutaneous coronary intervention: assessment using
instantaneous wave-free ratio. Heart 2013;99:1740–8.
[13] Nijjer SS, Sen S, Petraco R, Escaned J, Echavarria-Pinto M, Broyd C, et al. Pre-
angioplasty instantaneous wave-free ratio pullback provides virtual intervention
and predicts hemodynamic outcome for serial lesions and diffuse coronary artery
disease. JACC Cardiovasc Interv 2014;7:1386–96.
[14] Costa MA, Angiolillo DJ, Tannenbaum M, Driesman M, Chu A, Patterson J, et al. Im-
pact of stent deployment procedural factors on long-term effectiveness and safety
of sirolimus-eluting stents (ﬁnal results of the multicenter prospective STLLR trial).
Am J Cardiol 2008;101:1704–11.
[15] Mintz GS. Clinical Utility of Intravascular Imaging and Physiology in Coronary Artery
Disease. J Am Coll Cardiol 2014;64:207–22.
[16] Mauri L, O’Malley AJ, Popma JJ, Moses JW, Leon MB, Holmes DR, et al. Comparison of
thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus
bare metal stents. Am J Cardiol 2005;95:1140–5.
